EDB is involved in the regulation of endothelial cell proliferation and vascular morphogenesis; an EDB–specific radiolabeled antibody is currently on phase II clinical trials for anti-angiogenic cancer treatment [102]. The gene discussed is FN1; the disease is cancer.